Mateo Marin-Cuartas

Podcast

The Beat With Joel Dunning Ep. 158: JACC: Case Reports

May 28, 2026 | Joel DunningGold ContributorSilver Commentor…

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Dr. Gilbert Tang, Editor-in-Chief of Journal of the American College of Cardiology (JACC): Case Reports, professor in the Department of Cardiovascular Surgery at the...

Podcast

The Beat With Joel Dunning Ep. 158: JACC: Case Reports

May 28, 2026 | Joel DunningGold ContributorSilver Commentor…

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Dr. Gilbert Tang, Editor-in-Chief of Journal of the American College of Cardiology (JACC): Case Reports, professor in the Department...

Video

The Effects of Mitral Surgery on Ventricular Arrhythmias in Patients With Arrhythmic Mitral Valve Prolapse: An Interview With Dr. Michael Borger

May 22, 2026 | Mateo Marin-CuartasGold Contributor…

At the 2026 American Association for Thoracic Surgery (AATS) Annual Meeting, CTSNet JANS Editor Dr. Mateo Marin-Cuartas, a cardiac surgeon at Leipzig Heart Center, Germany, spoke with Dr. Michael Borger,...

Video

Updated 5-Year TAVR vs SAVR Outcomes in Low-Risk Patients: An Interview With Drs. Marin-Cuartas and Heuts

March 5, 2026 | Mateo Marin-CuartasGold Contributor…

In this outstanding interview, CTSNet Editor-in-Chief Joel Dunning speaks with Drs. Mateo Marin-Cuartas, CTSNet JANS Editor and cardiac surgeon at the University Department of Cardiac Surgery at Leipzig Heart Centre...

Podcast

The Beat With Joel Dunning Ep. 147: Updated 5-Year TAVR vs SAVR Outcomes in Low-Risk Patients

March 5, 2026 | Joel DunningGold ContributorSilver Commentor…

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Drs. Mateo Marin-Cuartas, CTSNet JANS Editor and cardiac surgeon at the University Department of Cardiac Surgery at Leipzig Heart...

JANS Article

Could the Age Threshold for TAVI be Relaxed to Below 65 Years? Pros and Cons

May 15, 2025 | Mateo Marin-CuartasGold Contributor

Transcatheter aortic valve implantation (TAVI) has emerged as the treatment of choice for symptomatic severe aortic stenosis (AS) across the whole surgical risk spectrum. Current European guidelines recommend surgical aortic...

JANS Article

Transcatheter vs. Surgical Aortic Valve Replacement in Women: The RHEIA Trial

May 1, 2025 | Mateo Marin-CuartasGold Contributor

Women with severe symptomatic aortic stenosis are underrepresented in clinical trials. The Randomized Research in Women All Comers with Aortic Stenosis (RHEIA) trial investigates the balance of benefits and risks...

JANS Article

5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

April 24, 2025 | Mateo Marin-CuartasGold Contributor

The Evolut Low Risk trial demonstrated that transcatheter aortic valve replacement (TAVR) was noninferior to surgery for the primary endpoint of all-cause mortality or disabling stroke at two years. In...

JANS Article

Long-Term Outcomes After Bioprosthetic Tricuspid Valve Replacement: A Multicenter Study

April 17, 2025 | Mateo Marin-CuartasGold Contributor

Long-term evidence about bioprosthetic tricuspid valve replacement is scarce. This study aims to investigate the long-term clinical outcomes of patients who underwent tricuspid valve replacement with bioprostheses. This multicenter retrospective...

JANS Article

Infective Endocarditis in Octogenarians—A Multicenter Analysis

April 10, 2025 | Mateo Marin-CuartasGold Contributor

In this study, the authors investigate the clinical presentation, microbiological profile, and outcomes of infective endocarditis in octogenarians. This multicenter retrospective analysis, utilizing data from the CAMPAIGN Registry, includes 4,917...

JANS Article

Mortality and Stroke After Routine Left Atrial Appendage Occlusion in Patients Undergoing Isolated Mitral Repair Without Atrial Fibrillation in the United States

April 3, 2025 | Mateo Marin-CuartasGold Contributor

In this study, the authors compared the long-term outcomes of patients who underwent left atrial appendage closure during mitral repair with those who did not, specifically in patients without atrial...

JANS Article

Challenges of Conventional and Novel Approaches to Clinical Trial Designs in Cardiovascular Medicine

March 20, 2025 | Mateo Marin-CuartasGold Contributor

In this article, the authors review the main limitations of conventional randomized controlled trial designs, present basic concepts of statistical analysis, and highlight features of novel designs and how they...

JANS Article

Percutaneous vs. Surgical Revascularization of Non-ST-Segment Elevation Myocardial Infarction With Multivessel Disease: The SWEDEHEART Registry

March 6, 2025 | Mateo Marin-CuartasGold Contributor

The debate continues over long-term outcomes of percutaneous coronary intervention (PCI) vs. coronary artery bypass grafting (CABG) in patients with non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel disease. This study,...

LOAD MORE
ADVERTISE ON CTSNET